PA
SLDB icon

Perceptive Advisors’s Solid Biosciences SLDB Stock Holding History

Perceptive Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13
Closed -$23K – 120
2019
Q2 		$23K Buy
+13
New +$1.42K ﹤0.01% 104
2019
Q1 		– Sell
-122
Closed -$14K – 117
2018
Q4 		$14K Buy
+122
New +$57.4K ﹤0.01% 101

Other funds holding SLDB

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors's SLDB Position: Q1 2026 in Review

Perceptive Advisors increased its Solid Biosciences (SLDB) stake by 0.62% in Q1 2026, buying an estimated $470K and bringing the position to 11,906,646 shares worth $85.7M. The position accounts for 1.68% of the portfolio, ranked #19.

Perceptive Advisors first reported a position in SLDB in Q4 2018 and has held it in 27 quarters since. The position peaked at $105M in Q4 2018. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Perceptive Advisors held 11,906,646 shares of Solid Biosciences worth $85.7M as of Q1 2026.
  • Perceptive Advisors bought 73,107 Solid Biosciences shares in Q1 2026, an estimated $470K.
  • Solid Biosciences made up 1.68% of Perceptive Advisors's portfolio in Q1 2026, its #19 holding.
  • Perceptive Advisors first reported a position in Solid Biosciences in Q4 2018 and has held it in 27 quarters since.
  • Perceptive Advisors's Solid Biosciences position peaked at $105M in Q4 2018.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.